Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nuclear Medicine and Cancer Theragnostics: Basic Concepts. | Diagnostics (Basel) | 2023 | 37835806 | PubTator, text mining | PubMed |
| Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future. | Cancers (Basel) | 2023 | 37835533 | PubTator, text mining | PubMed |
| Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy. | Cancers (Basel) | 2023 | 37835530 | PubTator, text mining | PubMed |
In Cerebellar Atrophy of 12-Month-Old ATM-Null Mice, Transcriptome Upregulations Concern Most Neurotransmission and Neuropeptide Pathways, While Downregulations Affect Prominently Itpr1, Usp2 and Non-Coding RNA. | Cells | 2023 | 37830614 | PubTator, text mining | PubMed |
| Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas. | Nat Commun | 2023 | 37805627 | PubTator, text mining | PubMed |
| Effective Treatment of SSTR2-Positive Small Cell Lung Cancer Using 211At-Containing Targeted α-Particle Therapy Agent Which Promotes Endogenous Antitumor Immune Response. | Mol Pharm | 2023 | 37788300 | PubTator, text mining | PubMed |
| Primary neuroendocrine neoplasms of the kidney: a case report and literature review. | J Int Med Res | 2023 | 37773688 | PubTator, text mining | PubMed |
| A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to 177Lutetium-DOTA-octreotate radionuclide therapy. | Theranostics | 2023 | 37771787 | PubTator, text mining | PubMed |
| An amide to thioamide substitution improves the permeability and bioavailability of macrocyclic peptides. | Nat Commun | 2023 | 37770425 | PubTator, text mining | PubMed |
| Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases. | J Clin Med | 2023 | 37762974 | PubTator, text mining | PubMed |
| Prolactin and Growth Hormone Signaling and Interlink Focused on the Mammosomatotroph Paradigm: A Comprehensive Review of the Literature. | Int J Mol Sci | 2023 | 37762304 | PubTator, text mining | PubMed |
| Epstein-Barr Virus Infection in Cancer. | Cancers (Basel) | 2023 | 37760627 | PubTator, text mining | PubMed |
| Three Dimensional Models of Endocrine Organs and Target Tissues Regulated by the Endocrine System. | Cancers (Basel) | 2023 | 37760571 | PubTator, text mining | PubMed |
| Novel Advances in Treatment of Meningiomas: Prognostic and Therapeutic Implications. | Cancers (Basel) | 2023 | 37760490 | PubTator, text mining | PubMed |
| Cervical intradural traumatic neuroma without history of trauma: illustrative case. | J Neurosurg Case Lessons | 2023 | 37756483 | PubTator, text mining | PubMed |
| Somatostatin Receptor-Directed PET/CT Can Differentiate Between Different Subtypes of Head and Neck Paragangliomas. | Clin Nucl Med | 2023 | 37756444 | PubTator, text mining | PubMed |
| Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors. | Sci Adv | 2023 | 37756410 | PubTator, text mining | PubMed |
| Antidotes in Clinical Toxicology-Critical Review. | Toxics | 2023 | 37755734 | PubTator, text mining | PubMed |
| Acromegaly: Pathophysiological Considerations and Treatment Options Including the Evolving Role of Oral Somatostatin Analogs. | Pathophysiology | 2023 | 37755395 | PubTator, text mining | PubMed |
| Narrative Review of Immunotherapy in Gastroentero-Pancreatic Neuroendocrine Neoplasms. | Curr Oncol | 2023 | 37754542 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=22